Outlook Therapeutics
OTLK
OTLK
73 hedge funds and large institutions have $45.3M invested in Outlook Therapeutics in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.03% more ownership
Funds ownership: 0.53% → 0.57% (+0.03%)
Holders
73
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.75M | |
| 2 | +$1.45M | |
| 3 | +$1.36M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$589K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$292K |
Top Sellers
| 1 | -$950K | |
| 2 | -$774K | |
| 3 | -$623K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$589K |
| 5 |
Millennium Management
New York
|
-$261K |